Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a

Oncology Letters

Volumn 14, Issue 4, 2017, Pages 4937-4942

  Mou, Shaofeng ^a   Zhou, Zhongxin ^a   He, Yukai ^a   Liu, Fuxing ^a   Gong, Lili ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis regulator Bcl 2; Curcumin; Laryngeal cancer; MicroRNA 15a; Phosphoinositide 3 kinase protein kinase B

Indexed keywords

BETA ACTIN; CASPASE 3; CURCUMIN; MICRORNA 15A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LARYNX SQUAMOUS CELL CARCINOMA; MTT ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 85028920006     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2017.6739     Document Type: Article

References (29)

1. Klatka J, Grywalska E, Klatka M, Wasiak M, Andrzejczak A and Rolinski J: Expression of selected regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer and their clinical significance. Eur Arch Otorhinolaryngol 270: 2683-2693, 2013.
2. Gilbert K, Dalley RW, Maronian N and Anzai Y: Staging of laryn- geal cancer using 64-channel multidetector row CT: Comparison of standard neck CT with dedicated breath-maneuver laryngeal CT. AJNR Am J Neuroradiol 31: 251-256, 2010.
3. Divi V, Worden FP, Prince ME, Eisbruch A, Lee JS, Bradford CR, Chepeha DB, Teknos TN, Hogikyan ND, Moyer JS, et al: Chemotherapy alone for organ preservation in advanced laryn- geal cancer. Head Neck 32: 1040-1047, 2010.
4. Mouw KW, Solanki AA, Stenson KM, Witt ME, Blair EA, Cohen EE, Vokes EE, List M, Haraf DJ and Salama JK: Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy. Oral Oncol 48: 1025-1030, 2012.
5. Ampil FL and Nguyen NP: Defining ‘upper mediastinal irra- diation’ in secondary subglottic laryngeal cancer. Oral Oncol 50: e15-e16, 2014.
6. Janssens GO, van Bockel LW, Doornaert PA, Bijl HP, van den Ende P, de Jong MA, van den Broek GB, Verbist BM, Terhaard CH, Span PN and Kaanders JH: Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: Results of the phase 3 ARCON trial. Eur J Cancer 50: 1112-1119, 2014.
7. Vachhani P, Bose P, Rahmani M and Grant S: Rational combina- tion of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML. Physiol Genomics 46: 448-456, 2014.
8. Yu X and Li Z: The role of MicroRNAs expression in laryngeal cancer. Oncotarget 6: 23297-23305, 2015.
9. Zhang Y, Chen Y, Yu J, Liu G and Huang Z: Integrated transcriptome analysis reveals miRNA-mRNA crosstalk in laryngeal squamous cell carcinoma. Genomics 104: 249-256, 2014.
10. Wu W, Geng H, Liu Z, Li H and Zhu Z: Effect of curcumin on rats/mice with diabetic nephropathy: A systematic review and meta-analysis of randomized controlled trials. J Tradit Chin Med 34: 419-429, 2014.
11. Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC and Kunnimalaiyaan M: Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: Molecular targeting in cholangiocarcinoma. J Surg Res 198: 434-440, 2015.
12. He Y, Yue Y, Zheng X, Zhang K, Chen S and Du Z: Curcumin, inflammation and chronic diseases: How are they linked? Molecules 20: 9183-9213, 2015.
13. Zhu L, Han MB, Gao Y, Wang H, Dai L, Wen Y and Na LX: Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes. Mol Med Rep 12: 1151-1156, 2015.
14. Zubillaga-Guerrero MI, Alarcón-Romero Ldel C, Illades-Aguiar B, Flores-Alfaro E, Bermúdez-Morales VH, Deas J and PeraltaZaragoza O: MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells. Int J Clin Exp Med 8: 15999-16006, 2015.
15. Koskinen WJ, Brøndbo K, Mellin Dahlstrand H, Luostarinen T, Hakulinen T, Leivo I, Molijn A, Quint WG, Røysland T, Munck-Wikland E, et al: Alcohol, smoking and human papillomavirus in laryngeal carcinoma: A Nordic prospective multicenter study. J Cancer Res Clin Oncol 133: 673-678, 2007.
16. Hamilton DW, de Salis I, Donovan JL and Birchall M: The recruitment of patients to trials in head and neck cancer: A qualitative study of the EaStER trial of treatments for early laryngeal cancer. Eur Arch Otorhinolaryngol 270: 2333-2337, 2013.
17. Tuorkey MJ: Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing. Interv Med Appl Sci 6: 139-146, 2014.
18. Sordillo PP and Helson L: Curcumin and cancer stem cells: Curcumin has asymmetrical effects on cancer and normal stem cells. Anticancer Res 35: 599-614, 2015.
19. Hosseini A, Sharifi AM, Abdollahi M, Najafi R, Baeeri M, Rayegan S, Cheshmehnour J, Hassani S, Bayrami Z and Safa M: Cerium and yttrium oxide nanoparticles against lead-induced oxidative stress and apoptosis in rat hippocampus. Biol Trace Elem Res 164: 80-89, 2015.
20. Besbes S, Mirshahi M, Pocard M and Billard C: New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget 6: 12862-12871, 2015.
21. Moldoveanu T, Follis AV, Kriwacki RW and Green DR: Many players in BCL-2 family affairs. Trends Biochem Sci 39: 101-111, 2014.
22. Bitting RL and Armstrong AJ: Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer 20: R83-R99, 2013.
23. Simpson DR, Mell LK and Cohen EE: Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol 51: 291-298, 2015.
24. Seo BR, Min KJ, Cho IJ, Kim SC and Kwon TK: Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability. PLoS One 9: e95588, 2014.
25. Zhao Z, Li C, Xi H, Gao Y and Xu D: Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Mol Med Rep 12: 5415-5422, 2015.
26. Li L, Zhang ZM, Liu Y, Wei MH, Xue LY, Zou SM, Di XB, Han NJ, Zhang KT, Xu ZG and Gao YN: DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx. Zhonghua Bing Li Xue Za Zhi 39: 391-395, 2010 (In Chinese).
27. Skawran B, Steinemann D, Becker T, Buurman R, Flik J, Wiese B, Flemming P, Kreipe H, Schlegelberger B and Wilkens L: Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma. Mod Pathol 21: 1479-1489, 2008.
28. Yang J, Cao Y, Sun J and Zhang Y: Curcumin reduces the expres- sion of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med Oncol 27: 1114-1118, 2010.
29. Gao SM, Yang JJ, Chen CQ, Chen JJ, Ye LP, Wang LY, Wu JB, Xing CY and Yu K: Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J Exp Clin Cancer Res 31: 27, 2012.